Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00851812 · ClinicalTrials.gov registry record · NA

Exercise for Breast Cancer Patients (EXCAP)

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
114
Enrollment target

NCT00851812: Completed NA study, sponsored by University of Rochester.

NCT00851812 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 114 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00851812, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
114 participants
Enrollment target

Study Summary

The purpose of this study is to examine if exercise helps improve cancer-related fatigue. Hypothesis: A structured home-based walking and progressive resistance exercise program will be efficacious in relieving cancer-related fatigue, preventing aerobic and anaerobic deconditioning and skeletal muscle wasting, as well as improving inflammatory cytokine profiles in breast cancer survivors as well as those receiving radiation treatment.

Interventions

  • BEHAVIORAL Exercise
  • BEHAVIORAL Progressive walking and resistance exercise treatment

Trial Details

FieldValue
Enrollment Target 114 participants
Start Date 2007-05
Est. Completion 2020-01-15
Phase NA
University of Rochester

636 total trials

What the finished NCT00851812 record still lists

NCT00851812 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Exercise is the first listed.

NCT00851812 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00851812 about?

NCT00851812 is a clinical study titled "Exercise for Breast Cancer Patients (EXCAP)". The purpose of this study is to examine if exercise helps improve cancer-related fatigue. Hypothesis: A structured home-based walking and progressive resistance exercise program will be efficacious in relieving cancer-related fatigue, preventing aerobic and anaerobic deconditioning and skeletal mus...

What is the current status of trial NCT00851812?

This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2007-05. Estimated completion is 2020-01-15.

What interventions are being tested in trial NCT00851812?

The interventions under investigation include: Exercise (BEHAVIORAL), Progressive walking and resistance exercise treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT00851812?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00851812's enrollment target sits among peer trials

114 811th of 2000 higher than 1,188 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04522791 · 114 participants · Phase 2

    Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)

  • NCT04875052 · 114 participants · NA

    Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury

  • NCT05100342 · 114 participants

    Prospective Validation of a Points Score System Predicting 30-day Survival

  • NCT05224089 · 114 participants · Phase 4

    Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00851812, the US trial registry maintained by the National Library of Medicine. NCT00851812 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.